PharmaLogic News and Resources

TAG1 Inc., a supplier of clinical quantities of medical isotopes, has announced a strategic partnership with PharmaLogic, a contract development and manufacturing organisation (CDMO) specialising in radiopharmaceuticals. The agreement will support TAG1’s transition from prototype to clinical-grade production of its Pb-212

PharmaLogic Holdings Corp., a contract development and manufacturing organization (CDMO) focused on radiopharmaceuticals, has finalised its acquisition of a majority stake in Norway-based Agilera Pharma AS. The stake was acquired from the Institute for Energy Technology (IFE). The deal marks

PharmaLogic Holdings Corp., a CDMO specialising in radiopharmaceuticals, has announced a leadership transition. Etienne Montagut, currently serving as President, will take over as President and Chief Executive Officer effective 1 June 2025. The change follows the retirement of Steve Chilinski,

PharmaLogic Holdings Corp. has announced it will acquire a majority stake in Agilera Pharma AS, a radiopharmaceutical manufacturing company based in Norway, from the Institute for Energy Technology (IFE). The move is a key element of PharmaLogic’s plan to establish the first

PharmaLogic Holdings Corp. , a contract development and manufacturing organisation (CDMO) specialising in radiopharmaceutical solutions, has officially opened its Los Angeles facility following extensive renovations. Acquired in 2022, this state-of-the-art centre is equipped with advanced technology to support the production and